期刊文献+

Effect of depression on the immune function and tumor load in patients with advanced gastric cancer

下载PDF
导出
摘要 Objective:To study the correlation between depression and immune function as well as tumor load in patients with advanced gastric cancer.Methods: 98 patients diagnosed with advanced gastric cancer in our hospital between May 2013 and September 2016 were selected and divided into depression group (n=39) with HAMD scores >50 and non-depression group with HAMD scores≤50 (n=39), serum was collected to detect the levels of cytokines interleukin-2 (IL-2), IL-4, IL-10, IL-17, interferon-γ (IFN-γ) and transforming growth factorβ1 (TGF-β1) as well as tumor markers carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199), CA724, TK-1 and sLAG-3, and gastric cancer tissues were collected to determine the expression of cell cycle-related proteins CyclinD1, CDK4 and E2F.Results:Serum IL-2, IFN-γand IL-17 levels of depression group were significantly lower than those of non-depression group (P<0.05) while IL-4, IL-10, TGF-β1, CEA, CA199, CA724, TK-1 and sLAG-3 levels were significantly higher than those of non-depression group (P<0.05);CyclinD1, CDK4 and E2F protein expression in tumor tissues of depression group were significantly higher than those of non-depression group (P<0.05).Conclusions:Depression can inhibit the anti-tumor immune response in patients with advanced gastric cancer, and then promote cancer cell proliferation and increase tumor load.
作者 Hai-Bo Shi
机构地区 Oncology Department
出处 《Journal of Hainan Medical University》 2017年第6期115-117,共3页 海南医学院学报(英文版)
  • 相关文献

参考文献3

二级参考文献48

  • 1唐丽,郑小华.三种肿瘤标志物联合检测胃癌的互补诊断价值[J].内蒙古医科大学学报,2012,34(S1):209-210. 被引量:1
  • 2刘复生.中国肿瘤病理学分类[M].北京:科学技术文献出版社,2001.225-226.
  • 3路宝士,赵立明.血清CA72-4、CA19-9检测联合全身骨显像在胃癌骨转移中的诊断价值[J].中外健康文摘,2013,(27):109-110.
  • 4Louhimo J , Kokkola A , Alfthan H , et at. Preopera- tive hCGbeta and CA 72-4 are prognostic factors in gas tric cancer [J] . Int J Cancer, 2004, 111 (6):929-933.
  • 5Ucar E,Semerci E,Ustun H,et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer[J]. Adv Ther, 2008, 25 (10) : 1075- 1084.
  • 6Peter C. Thuss-Patience,Albrecht Kretzschmar,Dmitry Bichev,Tillman Deist,Axel Hinke,Kirstin Breithaupt,Yasemin Dogan,Bernhard Gebauer,Guido Schumacher,Peter Reichardt.Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)[J].European Journal of Cancer.2011(15)
  • 7Sara Dosso,Elena Zanellato,Martina Nucifora,Renzo Boldorini,Angelica Sonzogni,Roberto Biffi,Nicola Fazio,Eraldo Bucci,Ottavio Beretta,Stefano Crippa,Piercarlo Saletti,Milo Frattini.ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy[J].Cancer Chemotherapy and Pharmacology.2013(1)
  • 8Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray.SJWD14121600000297[J]. Int. J. Cancer . 2015 (5)
  • 9Toshihiko Doi,Kei Muro,Narikazu Boku.Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer. Journal of Clinical Oncology . 2010
  • 10Yasutsuna Sasaki,Tomohiro Nishina,Hirofumi Yasui,Masahiro Goto,Kei Muro,Akihito Tsuji,Wasaburo Koizumi,Yasushi Toh,Takuo Hara,Yoshinori Miyata.Phase II trial of nanoparticle albumin‐bound paclitaxel as second‐line chemotherapy for unresectable or recurrent gastric cancer[J]. Cancer Sci . 2014 (7)

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部